ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2024 Earnings Call Transcript
Michael Miller: Good afternoon, everyone, and thank you for joining the third quarter 2024 ReShape Lifesciences' earnings call.
Reshape Weightloss Inc. (RSLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 0 | $0 | -100% | 0% |
| 2. | 0 | $0 | -100% | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
| $4.13 | 5,400 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
| $0.00 | 0 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
| $4.31 | 1,000 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
| $0.00 | 0 | Large Shareholder | 5,323,877 | 2020-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 20,487 | Director | 26,200 | 2017-12-19 | Filing | |
| $4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12.781,724,137,931 | $21,000 | 0% |
News See All
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the ReShape Lifesciences Second Quarter 2024 Earnings Call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the ReShape Lifesciences Second Quarter 2024 Earnings Call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2024 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the first quarter 2024 ReShape Lifesciences earnings call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences third quarter 2023 earnings call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences first quarter 2023 earnings call.
Billionaire Hedge Funds
